Literature DB >> 12199806

Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.

Fumihiko Hayakawa1, Kazumi Imada, Masayuki Towatari, Hidehiko Saito.   

Abstract

Infection of human parvovirus B19 (B19) is usually a self-limiting febrile illness, but can sometimes be life-threatening under certain circumstances, such as aplastic crisis in patients with haemolytic anaemia, hydrops fetalis in pregnant women and fulminant hepatitis. B19 can be transmitted through respiratory secretions, transplacentally and by transfusion of blood or blood products. In the present case, administration of intravenous immune globulin (i.v.Ig) transmitted B19 infection and consequently caused pure red cell aplasia and aggravation of hepatitis to fulminant hepatitis. Our case may raise important questions as to the safety of i.v.Ig and possible contamination by B19.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199806     DOI: 10.1046/j.1365-2141.2002.03741.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Haemolytic disease of the newborn.

Authors:  Neil A Murray; Irene A G Roberts
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03       Impact factor: 5.747

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.

Authors:  Kang Ning; Anuradha Roy; Fang Cheng; Peng Xu; Steve Kleiboeker; Carlos R Escalante; Jingxin Wang; Jianming Qiu
Journal:  J Virol       Date:  2021-10-20       Impact factor: 6.549

Review 4.  Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.

Authors:  Ting-Bo Liang; Dong-Lin Li; Jun Yu; Xue-Li Bai; Liang Liang; Shi-Guo Xu; Wei-Lin Wang; Yan Shen; Min Zhang; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

5.  Nuclease-resistant single-stranded DNA controls for nucleic acid amplification assays.

Authors:  Antje Gotsch; Andreas Schubert; Armin Bombis; Michael Wiedmann; Michael Zauke; Stefan Schorling
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

6.  Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia.

Authors:  Shigeki Ito; Tatsuo Oyake; Toshiyuki Uchiyama; Takeshi Sugawara; Kazunori Murai; Yoji Ishida
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

Review 7.  Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens.

Authors:  Kang Cai; Todd M Gierman; JoAnn Hotta; Christopher J Stenland; Douglas C Lee; Dominique Y Pifat; Steve R Petteway
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

Review 8.  The need for continuing vigilance: addressing the threat for transmission of blood-borne infectious disease.

Authors:  Samuel L Stanley
Journal:  Semin Hematol       Date:  2006-04       Impact factor: 3.851

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.